[1] Mallipattu SK, He JC. The podocyte as a direct target for treatment of glomerular disease?[J]. Am J Physiol Renal Physiol, 2016, 311: F46-F51. doi:10.1152/ajprenal.00184.2016. [2] Lei L, Mao Y, Meng D, et al. Percentage of circulating CD8+ T lymphocytes is associated with albuminuria in type 2 diabetes mellitus[J]. Exp Clin Endocrinol Diabetes, 2014, 122: 27-30.doi:10.1055/s-0033-1358666. [3] Hosseini Sarkhosh SM, Esteghamati A, Hemmatabadi M, et al. Predicting diabetic nephropathy in type 2 diabetic patients using machine learning algorithms[J]. J Diabetes Metab Disord, 2022, 21: 1433-1441. doi:10.1007/s40200-022-01076-2. [4] 孙凤起,武韧,常贵全,等. 肾小球系膜细胞增殖在糖尿病肾病肾小球硬化中作用的研究进展[J]. 基础医学与临床, 2021, 41: 1510-1513. [5] 刘瑞霞,郭兵,肖瑛,等. SnoN和Smad2/3信号蛋白与糖尿病大鼠肾小管-间质纤维化的关系[J]. 基础医学与临床, 2010, 30: 944-951. [6] Shemesh II, Rozen-Zvi B, Kalechman Y, et al. AS101 prevents diabetic nephropathy progression and mesangial cell dysfunction: regulation of the Akt downstream pathway[J]. PLoS One, 2014, 9: e114287. doi: 10.1371/journal.pone.0114287. [7] Li F, Fang Y, Zhuang Q, et al. Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis[J]. Kidney Int, 2022, 102: 121-135. doi: 10.1016/j.kint.2022.02.037. [8] Chen JK, Chen J, Thomas G, et al. S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy[J]. Am J Physiol Renal Physiol, 2009, 297: F585-F593. doi: 10.1152/ajprenal.00186.2009. [9] Dikic I, Elazar Z. Mechanism and medical implications of ma mmol/Lalian autophagy[J]. Nature Reviews. Nat Rev Mol Cell Biol, 2018, 19: 349-364. doi: 10.1038/s41580-018-0003-4. [10] Ferreira PMP, Sousa RWR de, Ferreira JR de O, et al. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms[J]. Pharmacol Res, 2021, 168: 105582. doi: 10.1016/j.phrs.2021.105582. [11] Wu YT, Tan HL, Shui G, et al. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class Ⅰ and Ⅲ phosphoinositide 3-kinase[J]. J Biol Chem, 2010, 285: 10850-10861. doi: 10.1074/jbc.M109.080796. [12] 庄梅琳, 程晶, 周亚明. 链脲佐菌素诱导建立糖尿病小鼠模型的给药方案研究[J]. 健康之路, 2018, 17: 21-22. [13] Kulkarni YA, Garud MS. Bauhinia variegata (Caesalpiniaceae) leaf extract: an effective treatment option in type Ⅰ and type Ⅱ diabetes[J]. Biomed Pharmacother, 2016, 83: 122-129. doi: 10.1016/j.biopha.2016.06.025. |